Central nervous system, cranial, and cerebrovascular conditions beyond the Kimonis criteria in patients with Gorlin syndrome: a retrospective cohort study.
- 1Department of Pediatrics, International University of Health and Welfare Narita Hospital, Narita, Japan.
- 2Department of Pediatrics, Graduate School of Medicine, Chiba University, Chiba, Japan.
Abstract
Background
Gorlin syndrome is a multisystem developmental and cancer-predisposing disorder commonly caused by germline PTCH1 variants. The Kimonis clinical criteria capture the canonical phenotype; however, central nervous system (CNS), cranial, and cerebrovascular conditions documented beyond these criteria remain poorly defined.Methods
We conducted a retrospective descriptive cohort study of 32 patients who fulfilled the Kimonis clinical criteria and received care at either or both hospitals in Japan. Clinical information through March 31, 2026, including sufficiently documented care elsewhere, was reviewed. The exploratory primary descriptive outcome was defined as the presence of at least one documented condition in three categories: structural CNS or cranial conditions, cerebrovascular disorders, or CNS neoplasms other than medulloblastoma. The three categories were considered separately.Results
A PTCH1 sequence variant or whole-gene deletion was documented in 24 of 32 patients. Eight patients had 10 documented findings representing eight conditions, including hydrocephalus, Chiari malformation, syringomyelia, moyamoya disease, and cerebral infarction. These findings were identified during routine longitudinal clinical care rather than systematic neuroimaging screening and therefore should not be interpreted as a prevalence estimate. Four patients underwent neurosurgical or cerebrovascular interventions.Conclusion
Clinically relevant CNS, cranial, and cerebrovascular conditions documented beyond the Kimonis criteria may warrant consideration when new neurological, respiratory, or craniocervical symptoms arise. Awareness of these conditions may inform symptom-directed differential diagnosis and the selection of imaging modalities and anatomical coverage. These exploratory findings do not establish a unified neurological phenotype or causal relationship with Gorlin syndrome and do not support universal neuroimaging surveillance in asymptomatic patients.
Related
- Sex-Specific Differences in Metabolic Syndrome Classification Using IDF Versus NCEP-ATP III Criteria: A Systematic Review and Head-to-Head Meta-Analysis
- Current clinical care for women with complete androgen insensitivity syndrome across the European reference network on rare endocrine conditions
- Clinical and MEFV variant characteristics of pediatric patients with an FMF-compatible phenotype and PFAPA-compatible features in a Palestinian referral cohort: a retrospective study
- Characteristics of Gut Microbiota in Patients with Polycystic Ovary Syndrome Across Different Traditional Chinese Medicine Syndrome Types.
- Psychopathological and psychosexual profile and therapy for patients with androgen insensitivity syndrome: a narrative review.
BibTeX
@article{arahata2026central,
title = {{Central nervous system, cranial, and cerebrovascular conditions beyond the Kimonis criteria in patients with Gorlin syndrome: a retrospective cohort study.}},
author = {Yukie Arahata and Katsunori Fujii and Daisuke Sawada and Tomoko Uchida and Takeshi Yaga and Tadashi Shiohama},
journal = {Frontiers in neurology},
year = {2026},
month = oct,
doi = {10.3389/fneur.2026.1935340},
url = {https://europepmc.org/article/MED/42903150},
note = {CC BY},
}
RIS
TY - JOUR
TI - Central nervous system, cranial, and cerebrovascular conditions beyond the Kimonis criteria in patients with Gorlin syndrome: a retrospective cohort study.
AU - Yukie Arahata
AU - Katsunori Fujii
AU - Daisuke Sawada
AU - Tomoko Uchida
AU - Takeshi Yaga
AU - Tadashi Shiohama
PY - 2026
DA - 2026/10/06
JO - Frontiers in neurology
DO - 10.3389/fneur.2026.1935340
UR - https://europepmc.org/article/MED/42903150
AB - Background Gorlin syndrome is a multisystem developmental and cancer-predisposing disorder commonly caused by germline PTCH1 variants. The Kimonis clinical criteria capture the canonical phenotype; however, central nervous system (CNS), cranial, and cerebrovascular conditions documented beyond these criteria remain poorly defined.Methods We conducted a retrospective descriptive cohort study of 32 patients who fulfilled the Kimonis clinical criteria and received care at either or both hospitals in Japan. Clinical information through March 31, 2026, including sufficiently documented care elsewhere, was reviewed. The exploratory primary descriptive outcome was defined as the presence of at least one documented condition in three categories: structural CNS or cranial conditions, cerebrovascular disorders, or CNS neoplasms other than medulloblastoma. The three categories were considered separately.Results A PTCH1 sequence variant or whole-gene deletion was documented in 24 of 32 patients. Eight patients had 10 documented findings representing eight conditions, including hydrocephalus, Chiari malformation, syringomyelia, moyamoya disease, and cerebral infarction. These findings were identified during routine longitudinal clinical care rather than systematic neuroimaging screening and therefore should not be interpreted as a prevalence estimate. Four patients underwent neurosurgical or cerebrovascular interventions.Conclusion Clinically relevant CNS, cranial, and cerebrovascular conditions documented beyond the Kimonis criteria may warrant consideration when new neurological, respiratory, or craniocervical symptoms arise. Awareness of these conditions may inform symptom-directed differential diagnosis and the selection of imaging modalities and anatomical coverage. These exploratory findings do not establish a unified neurological phenotype or causal relationship with Gorlin syndrome and do not support universal neuroimaging surveillance in asymptomatic patients.
SN - 1664-2295
ER -